Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioRestorative Therapies (BRTX) Treasury Shares (2016 - 2023)

Historic Treasury Shares for BioRestorative Therapies (BRTX) over the last 6 years, with Q2 2016 value amounting to $48875.0.

  • BioRestorative Therapies' Treasury Shares rose 5273.44% to $48875.0 in Q2 2016 from the same period last year, while for Jun 2016 it was $48875.0, marking a year-over-year increase of 5273.44%. This contributed to the annual value of $32000.0 for FY2015, which is 0.0% changed from last year.
  • Latest data reveals that BioRestorative Therapies reported Treasury Shares of $97827.0 as of Q4 2023, which was down 5153.96% from $97827.0 recorded in Q3 2023.
  • BioRestorative Therapies' 5-year Treasury Shares high stood at $1.2 billion for Q1 2021, and its period low was $97827.0 during Q1 2023.
  • Its 3-year average for Treasury Shares is $195.8 million, with a median of $211194.5 in 2022.
  • Per our database at Business Quant, BioRestorative Therapies' Treasury Shares changed by 0.0% in 2012 and then skyrocketed by 5273.44% in 2016.
  • BioRestorative Therapies' Treasury Shares (Quarter) stood at $32000.0 in 2012, then changed by 0.0% to $32000.0 in 2013, then changed by 0.0% to $32000.0 in 2014, then changed by 0.0% to $32000.0 in 2015, then surged by 52.73% to $48875.0 in 2016.
  • Its Treasury Shares was $48875.0 in Q2 2016, compared to $32000.0 in Q1 2016 and $32000.0 in Q4 2015.